# Drug Use Investigation for PAXIL Tablet

> **NCT01371435** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 3708 (actual)

## Conditions studied

- Mental Disorders

## Interventions

- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT01371435
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2005-09
- **Final completion:** 2005-12
- **Target enrollment:** 3708 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371435, "Drug Use Investigation for PAXIL Tablet". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01371435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*